RU2193877C2 - Агент для изменения роста волос в косметической или фармацевтической композиции, способ нетерапевтической обработки волос и набор - Google Patents
Агент для изменения роста волос в косметической или фармацевтической композиции, способ нетерапевтической обработки волос и набор Download PDFInfo
- Publication number
- RU2193877C2 RU2193877C2 RU2000127111/14A RU2000127111A RU2193877C2 RU 2193877 C2 RU2193877 C2 RU 2193877C2 RU 2000127111/14 A RU2000127111/14 A RU 2000127111/14A RU 2000127111 A RU2000127111 A RU 2000127111A RU 2193877 C2 RU2193877 C2 RU 2193877C2
- Authority
- RU
- Russia
- Prior art keywords
- benzoic acid
- retinoic acid
- hair
- composition
- acid
- Prior art date
Links
- 210000004209 hair Anatomy 0.000 title claims abstract description 23
- 230000003779 hair growth Effects 0.000 title claims abstract description 18
- 238000000034 method Methods 0.000 title claims abstract description 13
- 239000002537 cosmetic Substances 0.000 title claims abstract description 10
- 239000003795 chemical substances by application Substances 0.000 title claims abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 3
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims abstract description 53
- 230000000694 effects Effects 0.000 claims abstract description 53
- 229930002330 retinoic acid Natural products 0.000 claims abstract description 52
- 229960001727 tretinoin Drugs 0.000 claims abstract description 52
- 239000000203 mixture Substances 0.000 claims abstract description 39
- 239000003112 inhibitor Substances 0.000 claims abstract description 38
- 230000009885 systemic effect Effects 0.000 claims abstract description 5
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 31
- 235000010233 benzoic acid Nutrition 0.000 claims description 20
- 239000005711 Benzoic acid Substances 0.000 claims description 19
- 201000004384 Alopecia Diseases 0.000 claims description 17
- 230000003676 hair loss Effects 0.000 claims description 16
- -1 3-pyridylmethyl Chemical group 0.000 claims description 13
- 208000024963 hair loss Diseases 0.000 claims description 12
- 125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 claims description 4
- 230000008859 change Effects 0.000 claims description 4
- 230000001225 therapeutic effect Effects 0.000 claims description 4
- 230000012010 growth Effects 0.000 claims description 3
- 125000004289 pyrazol-3-yl group Chemical group [H]N1N=C(*)C([H])=C1[H] 0.000 claims description 2
- 150000001559 benzoic acids Chemical class 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 3
- 102000003702 retinoic acid receptors Human genes 0.000 description 27
- 108090000064 retinoic acid receptors Proteins 0.000 description 27
- 210000003491 skin Anatomy 0.000 description 21
- 150000001875 compounds Chemical class 0.000 description 14
- 239000005557 antagonist Substances 0.000 description 12
- 241000124008 Mammalia Species 0.000 description 10
- 239000000556 agonist Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 230000004044 response Effects 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 239000006210 lotion Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- JBALRFFXKQPVLT-UHFFFAOYSA-N 4-[7-(1-adamantyl)-6-(2-methoxyethoxymethoxy)naphthalen-2-yl]benzoic acid Chemical compound C1=C2C=C(C34CC5CC(CC(C5)C3)C4)C(OCOCCOC)=CC2=CC=C1C1=CC=C(C(O)=O)C=C1 JBALRFFXKQPVLT-UHFFFAOYSA-N 0.000 description 3
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- NCEQLLNVRRTCKJ-UHFFFAOYSA-N 4-[2-[5,5-dimethyl-8-(4-methylphenyl)-6h-naphthalen-2-yl]ethynyl]benzoic acid Chemical compound C1=CC(C)=CC=C1C1=CCC(C)(C)C2=CC=C(C#CC=3C=CC(=CC=3)C(O)=O)C=C12 NCEQLLNVRRTCKJ-UHFFFAOYSA-N 0.000 description 2
- JGDKPWGYKJEHTL-UHFFFAOYSA-N 4-[7-(1-adamantyl)-6-(2-methoxyethoxymethoxy)naphthalen-2-yl]-2-hydroxybenzoic acid Chemical compound C1=C2C=C(C34CC5CC(CC(C5)C3)C4)C(OCOCCOC)=CC2=CC=C1C1=CC=C(C(O)=O)C(O)=C1 JGDKPWGYKJEHTL-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 108090000128 Lipoxygenases Proteins 0.000 description 2
- 102000003820 Lipoxygenases Human genes 0.000 description 2
- 102000001938 Plasminogen Activators Human genes 0.000 description 2
- 108010001014 Plasminogen Activators Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000016507 interphase Effects 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 229960003632 minoxidil Drugs 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 229940127126 plasminogen activator Drugs 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000002599 prostaglandin synthase inhibitor Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 238000007910 systemic administration Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- ZIMGGGWCDYVHOY-UHFFFAOYSA-N 3-hydroxy-2-imino-6-(1-piperidinyl)-4-pyrimidinamine Chemical compound N=C1N(O)C(N)=CC(N2CCCCC2)=N1 ZIMGGGWCDYVHOY-UHFFFAOYSA-N 0.000 description 1
- VFJRAHTYLDXECD-UHFFFAOYSA-N 6-[7-(1-adamantyl)-6-(2-methoxyethoxymethoxy)naphthalen-2-yl]pyridine-3-carboxylic acid Chemical compound C1=C2C=C(C34CC5CC(CC(C5)C3)C4)C(OCOCCOC)=CC2=CC=C1C1=CC=C(C(O)=O)C=N1 VFJRAHTYLDXECD-UHFFFAOYSA-N 0.000 description 1
- SHGAZHPCJJPHSC-ZVCIMWCZSA-N 9-cis-retinoic acid Chemical compound OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-ZVCIMWCZSA-N 0.000 description 1
- 238000011740 C57BL/6 mouse Methods 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 101000883061 Chassalia parviflora Circulin-D Proteins 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 229940122204 Cyclooxygenase inhibitor Drugs 0.000 description 1
- 208000003024 Diffuse alopecia Diseases 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 206010020112 Hirsutism Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108020005497 Nuclear hormone receptor Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108091027981 Response element Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229960001445 alitretinoin Drugs 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 230000001548 androgenic effect Effects 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000005518 carboxamido group Chemical group 0.000 description 1
- 230000003778 catagen phase Effects 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 208000012412 genetic alopecia Diseases 0.000 description 1
- 230000003648 hair appearance Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 201000006122 hypervitaminosis A Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 102000006255 nuclear receptors Human genes 0.000 description 1
- 108020004017 nuclear receptors Proteins 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000017363 positive regulation of growth Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002464 receptor antagonist Substances 0.000 description 1
- 229940044551 receptor antagonist Drugs 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 208000001608 teratocarcinoma Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
- A61Q7/02—Preparations for inhibiting or slowing hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/603—Salicylic acid; Derivatives thereof having further aromatic rings, e.g. diflunisal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9803978 | 1998-03-31 | ||
| FR9803978A FR2776511B1 (fr) | 1998-03-31 | 1998-03-31 | Utilisation dans ou pour la preparation d'une composition d'au moins un inhibiteur de l'activite de l'acide retinoique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2000127111A RU2000127111A (ru) | 2002-09-27 |
| RU2193877C2 true RU2193877C2 (ru) | 2002-12-10 |
Family
ID=9524693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2000127111/14A RU2193877C2 (ru) | 1998-03-31 | 1999-03-24 | Агент для изменения роста волос в косметической или фармацевтической композиции, способ нетерапевтической обработки волос и набор |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1066017A1 (fr) |
| JP (1) | JP2002509870A (fr) |
| KR (1) | KR20010042104A (fr) |
| CN (1) | CN1298290A (fr) |
| AR (1) | AR015551A1 (fr) |
| AU (1) | AU2938899A (fr) |
| BR (1) | BR9908411A (fr) |
| CA (1) | CA2324899A1 (fr) |
| FR (1) | FR2776511B1 (fr) |
| HU (1) | HUP0102411A3 (fr) |
| IL (1) | IL137859A0 (fr) |
| NO (1) | NO20004880L (fr) |
| PL (1) | PL343004A1 (fr) |
| RU (1) | RU2193877C2 (fr) |
| WO (1) | WO1999049838A1 (fr) |
| ZA (1) | ZA200004483B (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2270667C2 (ru) * | 2003-09-01 | 2006-02-27 | Лариса Яковлевна Циукаева | Лосьон против роста волос (варианты) и способ замедления роста волос |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2733684B1 (fr) * | 1995-05-03 | 1997-05-30 | Cird Galderma | Utilisation de retinoides dans une composition cosmetique ou pour la fabrication d'une composition pharmaceutique |
| FR2739777B1 (fr) * | 1995-10-11 | 1997-11-14 | Cird Galderma | Ligand antagoniste rar-gamma ou agoniste rar-alpha en tant qu'inhibiteur d'apoptose |
| US5965606A (en) * | 1995-12-29 | 1999-10-12 | Allergan Sales, Inc. | Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity |
| JP3995716B2 (ja) * | 1996-03-18 | 2007-10-24 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 縮合環含有カルボン酸誘導体 |
-
1998
- 1998-03-31 FR FR9803978A patent/FR2776511B1/fr not_active Expired - Fee Related
-
1999
- 1999-03-24 CA CA002324899A patent/CA2324899A1/fr not_active Abandoned
- 1999-03-24 IL IL13785999A patent/IL137859A0/xx unknown
- 1999-03-24 WO PCT/FR1999/000687 patent/WO1999049838A1/fr not_active Ceased
- 1999-03-24 BR BR9908411-2A patent/BR9908411A/pt not_active IP Right Cessation
- 1999-03-24 RU RU2000127111/14A patent/RU2193877C2/ru active
- 1999-03-24 EP EP99910423A patent/EP1066017A1/fr not_active Withdrawn
- 1999-03-24 PL PL99343004A patent/PL343004A1/xx not_active Application Discontinuation
- 1999-03-24 AU AU29388/99A patent/AU2938899A/en not_active Abandoned
- 1999-03-24 CN CN99804411A patent/CN1298290A/zh active Pending
- 1999-03-24 HU HU0102411A patent/HUP0102411A3/hu unknown
- 1999-03-24 JP JP2000540805A patent/JP2002509870A/ja active Pending
- 1999-03-24 KR KR1020007010470A patent/KR20010042104A/ko not_active Ceased
- 1999-03-30 AR ARP990101412A patent/AR015551A1/es unknown
-
2000
- 2000-08-29 ZA ZA200004483A patent/ZA200004483B/en unknown
- 2000-09-28 NO NO20004880A patent/NO20004880L/no unknown
Non-Patent Citations (1)
| Title |
|---|
| ГУЗЕВ К.С. Лекарственные препараты с ретиноидами (Обзор). Скорая помощь. - М., 1994, № 3, с. 38-39. * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2270667C2 (ru) * | 2003-09-01 | 2006-02-27 | Лариса Яковлевна Циукаева | Лосьон против роста волос (варианты) и способ замедления роста волос |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1066017A1 (fr) | 2001-01-10 |
| ZA200004483B (en) | 2002-02-27 |
| NO20004880L (no) | 2000-11-30 |
| BR9908411A (pt) | 2000-12-05 |
| AR015551A1 (es) | 2001-05-02 |
| FR2776511B1 (fr) | 2001-05-11 |
| WO1999049838A1 (fr) | 1999-10-07 |
| FR2776511A1 (fr) | 1999-10-01 |
| IL137859A0 (en) | 2001-10-31 |
| AU2938899A (en) | 1999-10-18 |
| NO20004880D0 (no) | 2000-09-28 |
| PL343004A1 (en) | 2001-07-30 |
| HUP0102411A3 (en) | 2002-12-28 |
| KR20010042104A (ko) | 2001-05-25 |
| CA2324899A1 (fr) | 1999-10-07 |
| CN1298290A (zh) | 2001-06-06 |
| JP2002509870A (ja) | 2002-04-02 |
| HUP0102411A2 (hu) | 2001-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20020044953A1 (en) | Use of non-prostanoic agonists of prostaglandin EP-2 and/or EP-4 receptors as cosmetic agents for attenuating, reducing or stopping the loss of head hair and other hairs | |
| ES2198662T3 (es) | Uso de retinoides como agente inductor de la pigmentacion de la piel. | |
| US5739111A (en) | Modulating body/cranial hair growth with derivatives of the α-type melanocyte-stimulating hormone | |
| CA2082505C (fr) | Mode de traitement de l'alopecie | |
| US5514672A (en) | Use of retinoids and compositions containing same for hair growth | |
| JPH06500081A (ja) | カリウムチャネルオープナーおよび５α―レダクターゼ抑制剤を用いる育毛刺激 | |
| JP2017197585A (ja) | 発毛を調節するための組成物および方法 | |
| CN110831601B (zh) | 三部分组成的雄激素受体消除剂、其方法和用途 | |
| RU2316325C2 (ru) | Гетероциклическое соединение, стимулирующее или вызывающее рост волос или ресниц и/или препятствующее их выпадению, композиция, содержащая соединение, ее применение | |
| Billoni et al. | Expression of peroxisome proliferator activated receptors (PPARs) in human hair follicles and PPAR alpha involvement in hair growth | |
| AU707390B2 (en) | Use of inhibitors of the activity of retinoic acid to promote healing | |
| US9993518B2 (en) | Association of a tetrapeptide and a glyceryl ester for treating androgenic alopecia | |
| RU2568833C2 (ru) | Применение 2,3-дигидроксипропилдодеканоата для лечения себореи | |
| US20020052416A1 (en) | Use of prostaglandin EP-3 receptor antagonists as cosmetic agents for attenuating, reducing or stopping the loss of head hair and other hairs | |
| RU2193877C2 (ru) | Агент для изменения роста волос в косметической или фармацевтической композиции, способ нетерапевтической обработки волос и набор | |
| US5827500A (en) | Process for identifying RAR-receptor-antagonist compounds | |
| MXPA00008971A (en) | Use of retinoic acid activity inhibitors to slow down hair loss | |
| AU2013301601B2 (en) | Eprotirome for use in the prevention and/or treatment of hair disorders and compositions thereof | |
| JP2004331664A (ja) | ピリミジン−ｎ−オキシド誘導体を含有する毛髪用組成物、ケラチン繊維の成長を刺激し及び／又は抜毛を減少させるためのその使用 | |
| JP2004518701A (ja) | カリウムチャネル開口薬およびプロテインキナーゼｃ阻害薬の新規な組成物ならびにそれらの使用 | |
| Anastassakis | Retinoic Acid | |
| AU2023271433A1 (en) | Olfactory receptor 2a4/7 agonist for promoting hair growth and improving aesthetic aspect | |
| JPH03153610A (ja) | 美白化粧料 | |
| JP2001302494A (ja) | スキンケア用のレチノイドおよびカフェインを含有する組成物 |